<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="52" height="12" font="1">Jun 25, 2011</text>
<text top="359" left="94" width="415" height="12" font="1">Affinity purified, rabbit polyclonal, raised against amino acids 139-347 of recombinant human NFYA.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="112" height="12" font="1">jfleming@hms.harvard.edu</text>
<text top="134" left="83" width="66" height="12" font="1">Joseph Fleming</text>
<text top="215" left="121" width="23" height="12" font="1">NFYA</text>
<text top="215" left="339" width="23" height="12" font="1">NFYA</text>
<text top="170" left="230" width="25" height="12" font="1">Struhl</text>
<text top="255" left="239" width="284" height="12" font="1">Donated by Prof. R. Mantovani, Universita degli Studi di Milano, Italy </text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="112" height="12" font="1">NA (from academic source)</text>
<text top="300" left="215" width="45" height="12" font="1">Mantovani</text>
<text top="521" left="395" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="425" left="94" width="408" height="12" font="1">NFYA is the alpha subunit of the heterotrimeric NFY transcription factor complex that binds to the </text>
<text top="437" left="94" width="103" height="12" font="1">ubiquitous CCAAT motif.</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="128" left="125" width="434" height="12" font="1">Nuclear extract, of the indicated cell lines, were separated on a 10% gel using SDS-PAGE, transferred to a </text>
<text top="140" left="125" width="424" height="12" font="1">PDF membrane and Western blotted using standard protocols. Primary antibody (anti-NFYA, gift from </text>
<text top="152" left="125" width="434" height="12" font="1">Prof. R. Mantovani) and secondary antibody (SC-2317, Santa Cruz Biotechnology) were used at a dilution </text>
<text top="164" left="125" width="416" height="12" font="1">of 1:2500 and 1:4000, respectively. Signal was detected using Luminol Reagent (SC-2048, Santa Cruz </text>
<text top="176" left="125" width="394" height="12" font="1">Biotechnology). Detection of the known short and long NFYA isoforms are indicated by arrows.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="117" left="130" width="414" height="12" font="1">HeLaS3 nuclear extract (5x10^7cells/IP) was incubated with 10ug of anti-NFYA or normal rabbit IgG </text>
<text top="129" left="130" width="421" height="12" font="1">(SC-2027, Santa Cruz Biotechnology) and immunoprecipitated with protein A sepharose beads. Input </text>
<text top="141" left="130" width="396" height="12" font="1">nuclear extract, supernatant after IP and elution fractions were analysed by Western blotting as </text>
<text top="153" left="130" width="409" height="12" font="1">above, except: 10-14% gradient gel, 1:700 dilution anti-NFYA. Specific immunoprecipitation of the </text>
<text top="165" left="130" width="377" height="12" font="1">short and long NFYA isoforms was observed only in the anti-NFYA IP (indicated by arrows). </text>
<text top="177" left="130" width="2" height="12" font="1"> </text>
<text top="189" left="130" width="413" height="12" font="1">Additional validation was carried out by observing specific ChIP-QPCR signals at known NFY bound </text>
<text top="201" left="130" width="424" height="12" font="1">genomic loci, and by comparison to NFYB ChIP-Seq data showing high degree of correlation between </text>
<text top="213" left="130" width="394" height="12" font="1">NFYA and NFYB read counts at NFY bound regions across 3 cell lines (Pearson correlation &gt;0.7).</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
